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Abstract: Melanoma antigen family (MAGE) genes are widely expressed in various tumor types but silent in normal cells except 
germ-line  cells  lacking  human  leukocyte  antigen  (HLA)  expression.  Over  25  MAGE  genes  have  been  identified  in  different 
tissues, mostly located in Xq28 of human chromosome and some of them in chromosome 3 and 15, containing either single or 
multiple-exons. This in silico study predicted the genes on hTERT location and identified a distant relative of MAGE gene located on 
chromosome 5. The study identified a single exon coding ∼850 residues polypeptide sharing ∼30% homology with Macfa-MAGE E1 
and hMAGE-E1. dbEST search of the predicted transcript matches 5' and 3' flanking ESTs. The predicted protein showed sequence 
homology within the MAGE homology domain 2 (MHD2). UCSC genome annotation of CpG Island around the coding region reveals 
that this gene could be silent by methylation. Affymetrix all-exon track indicates the gene could be expressed in different tissues 
particularly in cancer cells as they widely undergo a genome wide demethylation process.
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Introduction
Human telomerase, a cellular reverse transcriptase, 
is a ribonucleoprotein enzyme that catalyzes the syn-
thesis and extension of telomeric DNA.1 Telomerase 
activity appears to be associated with cell immortal-
ization and malignant progression.2 Usually human 
telomerase is found in hemopoietic and in germ cells 
but not in normal somatic cells. Active telomerase is 
one of the key factors that enable malignant cells to 
proliferate indefinitely.3 However, molecular mecha-
nisms  triggering  various  telomerase  activities  still 
remain elusive.
In  this  post-genomic  era,  in  silico  techniques 
for  gene  finding  process  or  identifying  the  loca-
tion  of  the  protein-coding  regions  (ORF),  within 
uncharacterized genomic DNA sequences, consti-
tute a central issue in the field of bioinformatics4 
and are of much interest to biologists. A number 
of computational techniques for the prediction of 
distinctive features of protein-coding regions have 
been proposed along with the standard molecular 
methods. In general, the two main approaches of 
structural gene prediction are intrinsic (based on 
statistical  properties  of  exons,  splice  sites,  and 
other  signals)  and  extrinsic  (based  on  homology 
with known genes).5
In this study, the human chromosome 5p13.1–p15.33 
region containing the telomerase (hTERT) gene was 
investigated  by  using  both  intrinsic  and  extrinsic 
method of gene prediction. In addition to hTERT ORF, 
two additional ORFs named gene2 and gene3 were 
identified. Interestingly, predicted gene2 revealed sig-
nificant sequence homology with human tumor specific 
antigen, melanoma antigen family gene (MAGE), E1.
Materials and Methods
Complete  sequence  of  human  telomerase  reverse 
transcriptase  (hTERT)  was  retrieved  from  NCBI 
(gi:82399156, Accession no. DQ264729.1).
In silico identification of ORFs
The  coding  sequences  of  hTERT  were  identified 
using NCBI’s ORF Finder (http://www.ncbi.nlm.nih.
gov/gorf). The sequence (DQ264729.1) was further 
analyzed using various ab initio gene finding programs 
(GENSCAN, FGENESH and AUGUSTUS) and by 
comparative gene prediction (TWINSCAN) methods. 
The  genomic  location  of  the  hTERT  was  studied 
using  the  UCSC  Genome  browser  (http://genome.
ucsc.edu/cgibin/hgGateway). This browser was also 
used  to  identify  the  CpG  Island  track  and  EST’s 
around  the  predicted  ORF.  The  5'-UTR  of  the 
predicted transcription start site (TSS), the start codon 
and the 3'-UTR, 1000 bp downstream from the stop 
codon were searched using BLASTn, against the EST 
database (dbEST).
homology study of the predicted oRFs
The homologous sequences of the predicted genes 
were  identified  from  successive  iterations  using 
PSI-BLAST. Multiple sequences were aligned using 
ClustalW (1.83) (http://www.ebi.ac.uk/tools/clustalw). 
Secondary  structure  of  the  predicted  gene2  was 
analyzed  using  the  program  Hierarchical  Neural 
Network (HNN: http://www.expasy.org/tools/). The 
repeated  pattern  motifs  were  analyzed  using  the 
program Rapid Automatic Detection and Alignment 
of Repeats RADAR (http://ebi.ac.uk/radar/).
Comparative genomics analysis  
of the predicted gene2
Global alignment of the coding sequence of gene2 
with Chimpanzee (Pan troglodytes) and Orangutan 
(Pongo  pygmaeus-abelii)  genomic  sequence  was 
performed with the program AVID using a window 
size of 100 bp and a conservation level of 70%. Results 
were  viewed  with  the  program  VISTA.6  Finally, 
the nucleotide sequence of the Chimpanzee TERT 
(Pan troglodytes chromosome 5 genomic contig, 
reference assembly, Accession no. NW_001235370, 
region: 211936-253254) was further analysed by using 
GENSCAN  to  confirm  the  presence  of  conserved 
gene2 in Chimpanzee genome.
prediction of the function of the gene2
The function of gene2 was predicted using two protein 
function prediction program PFP7 and SVMProt.8 For 
comparative analysis, function of MAGE-E1 was also 
predicted using these two programs.
Result and Discussion
Table 1 showed the gene prediction analysis of hTERT 
by  different  programs.  GENSCAN9  had  predicted 
4 genes within the same hTERT location. Interestingly, 
apart from the known hTERT splice variant (gene1 
and gene4 on the +strand), this program also predicted Cancer-associated gene identification in silico
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Table 1. summary of the gene prediction analysis result of gene2 and gene3.
Gene prediction  
Program
predicted  
Genes
strand Features start end
GenscAn gene2 Complement promoter 9515 9476
Initial exon 9155 9102
Internal exon 7861 5671
Terminal exon 5518 5064
poly A site 4718 4713
gene3 Complement promoter 16734 16116
Initial exon 16386 16116
Internal exon 14465 13849
Terminal exon 13831 12458
poly A site 9749 9744
AUGUsTUs gene2 Complement CDs 7869 5617
gene3 Complement CDs-1 14225 13860
CDs-2 13689 12469
FGENESH gene2 Complement Tss 9618 9618
exon-1 7858 5606
poly A site 4723 4723
gene3 Complement Tss 16699 16699
exon-1 16195 16116
exon-2 13907 12458
poly A site 11428 11428
TWInscAn gene2 Complement exon-1 7858 5606
gene3 Complement Initial exon 16386 16116
Internal exon 14465 13849
Terminal exon 13831 12458
ORF Finder gene2 Complement oRF in  
Frame-2
7858 5606
gene3 Complement oRF in  
Frame-3
13122 12106
two additional genes in the reverse strand, namely 
gene2 (9155–5064 bp) and gene3 (16386–12458 bp) 
both of which consists of 3 exons. AUGUSTUS10 also 
identified two genes in the reverse strand at a slightly 
different location- gene2 (7869–5617 bp) consists of 
a single exon whereas gene3 (14225–12469 bp) con-
sists of two exons. The predicted genes in the reverse 
strand were confirmed by the FGENESH and ORF 
Finder. Homology-based program TWINSCAN11 also 
predicted two reverse strand genes in the same way as 
FGENESH and ORF Finder (Table 1).
In UCSC genome browser, two different gene pre-
diction  tracks  NSCAN  and  GeneID  also  predicted 
the  location  of  the  gene2  and  gene3  (Fig.  1). 
Tissue-specific  expression  pattern  of  the  predicted 
genes  was  hypothesized  by  observing  Affyme-
trix  all-exon  track. The  genome  browser  also  pre-
dicted the CpG island around the predicted genes. 
A  good  number  of  ESTs  were  identified  at  the  5' 
and 3' flanking regions for both the predicted gene2 
and  gene3.  The  predicted  ESTs  showed  different 
expression profiles in different tissue types. Interest-
ingly for the predicted gene2 it has been found that 
in some tissue types the gene is expressed in devel-
opmental stages and in others expressed in different 
cancer cell lines (Fig. 1). Similar patterns were also Amin et al
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observed for the predicted gene3 and revealed that it 
shares good 5' flanking region (∼99% identity) with 
the  clone  collection  from  IMAGE  cDNA,  mRNA 
database sequences (Supplementary data).
VISTA  plot  of  the  AVID  alignment  (Fig.  2) 
indicated that majority of the region in gene2 is highly 
conserved  (92%  identity)  in  Chimpanzee  and 
Orangutan genome. No larger repeats (LINE, SINE, 
and LTR) were observed within that region. Further 
GENSCAN  analysis  of  the  corresponding  TERT 
region on Chimpanzee chromosome 5 indicated that 
this  region  also  contain  a  putative  gene  encoding 
Figure 1. UCSC Genome Browser analysis showing the location of the predicted genes. Affymetrix All Exon Chip-Array tracks are used for tissue specific 
gene expression. CpG Island is also observed around the predicted gene.
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Figure 2. Conservation of gene2 in Chimpanzee (Pan troglodytes) and orangutan (Pongo pygmaeus-abelii) on VIsTA browser.Cancer-associated gene identification in silico
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Table 2. summary of the homologous sequences of predicted gene2.
GI no. Accession no. name of the protein Length (aa) Identity (%) similarity (%) e-value
67604778 Xp_666642.1 Cell surface protein that 
may regulate cell wall 
beta-glucan synthesis 
and bud site selection 
[Cryptosporidium 
hominis TU502]
999 27.76 48.53 2e-28
88602575 yp_502753.1 Mucin 2, intestinal/trac
heal[Methanospirillum 
hungatei JF-1]
2353 27.69 36.69 6e-26
66363458 Xp_628695.1 serine/threonine rich 
low complexity protein 
[Cryptosporidium parvum 
Iowa II]
951 27.25 51.0 8e-23
71402846 Xp_804287.1 Cellulosomal scaffoldin 
anchoring protein 
[Trypanosoma cruzi 
strain CL Brener]
928 40.67 44.33 2e-08
114771991 Zp_01449380.1 Fibronectin type III 
domain protein [alpha 
proteobacterium 
hTCC2255]
2282 25.0 38.33 2e-08
52144448 yp_082380.1 Collagen-binding surface 
protein [Bacillus cereus 
e33L]
913 25.38 30.85 4e-08
50401145 Q9Be18 Melanoma-associated 
antigen e1 (MAGe-e1 
antigen) Macfa
957 28.0 41.0 5e-08
89095693 Zp_01168587.1 RTX toxins and related 
Ca2+-binding protein 
[Bacillus sp. NRRL 
B-14911]
1415 23.33 38.0 1e-04
29792032 AAh50588.1 Melanoma antigen  
family e, 1 [Homo 
sapiens]
957 28.0 41.67 6e-04
118716717 Zp_01569254.1 hemagluttinin domain 
protein [Burkholderia 
multivorans ATCC 
17616]
1487 25.4 50.0 0.004
748  amino  acids  protein  which  is  very  much 
similar  (82%  identity  and  84%  similarity)  to  the 
predicted  gene2  of  hTERT  region  (Supplementary 
data).  Identification  of  the  blocks  of  genes  with 
evolutionary conserved order in multiple genomes is 
an important issue in comparative genomics. These 
synteny blocks help in tracing back the evolution of 
genomes in terms of rearrangement event. Presence 
of conserved blocks of genes in multiple genomes 
may indicate functional relatedness of their products 
or  presence  of  functionally  important  conserved 
non-coding regions.12 Through comparative genomics 
analysis of our predicted gene2, we have found that 
this gene is conserved in different genomes in terms 
of gene order.
BLAST results indicated that gene2 shared some 
homology  (∼38%–41%)  with  the  MAGE  E1,  a 
member of type II melanoma antigen family (Table 2). 
MAGE family is a large family which comprises over 
25 members identified in human. Most members of 
the MAGE family are clustered at the Xq28 region 
of  human  chromosome.13  The  overall  structure  of Amin et al
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MAGE-E1, and Macfa MAGE-E1 are larger proteins 
with  extended  N  or  C-termini.  The  N-terminal 
domain of MAGE-E1, contains a loosely conserved 
region of ∼220 amino acids, termed MHD2 domain.14 
Global  alignment  in  ClustalW  showed  loosely 
conserved  regions  for  both  amino-terminal  and 
carboxy-terminal  domain  of  gene2  with  human 
MAGE family E1 (accession no.AAH50588.1) and 
MAGE1_Macfa,  Melanoma  associated  antigenE1 
(accession no.Q9BE18) (Fig. 3).
Identification  of  the  novel  members  of  a  large 
protein  family  is  very  difficult  as  the  similarity 
searching programs are designed to highlight the most 
similar sequences. As a result, about 5% of the novel 
protein family members may remain unrecognized.15 
In an example by Retief et al,15 the large family of 
known  glutathione  transferase  proteins  was  first 
subjected  to  multiple  sequence  alignment,  and  a 
phylogenetic tree was made by distance methods to 
identify classes of proteins within the family. These 
proteins represented a broad range of phylogenetic 
context  and  included  classes  with  sometimes  less 
than 20% identity.16 Thus, in spite of having ∼40% 
sequence homology with MAGE-E1, predicted gene2 
may be a novel member of melanoma antigen family 
(MAGE).
Expression  pattern  of  different  members  of  the 
MAGE family genes are different and tissue specific, 
some encodes tumor specific antigens and some are 
expressed in normal cells.17,18 Besides, co-expression 
Figure 3. Global alignment of gene2 with MAGe homology domain (MhD).Cancer-associated gene identification in silico
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Table 3. Repeated sequence motif of the predicted gene2 
analyzed by RADAR.
pattern  of  some  tumour  associated  antigen  (TAA) 
including 5 MAGE-A genes with human telomerase 
reverse transcriptase was observed in non-small cell 
lung carcinoma (NSCLC) such as adenocarcinoma, 
squamous cell carcinoma and bronchiolocarinomas.19 
5' flanking EST analysis of predicted gene2 revealed 
that most of the ESTs are expressed in several cancer 
cells. As human telomerase activity is observed only 
in germline and cancer cells2 and its co-expression 
patterns was observed with some MAGE gene, our 
predicted gene2 may be co-expressed with telomer-
ase in cancer cells.
Transcriptional regulation of MAGE gene family is 
dependent on various factors. Promoter methylation is 
one of these factors. Methylated CpG point in the pro-
moter region is responsible for transcriptional silencing 
of the MAGE gene.20 Demethylation of the MAGE1 
promoter appears to be sufficient to activate this gene 
in tumor cell lines.21 From UCSC genome browser, we 
have observed the presence of CpG island around our 
predicted gene2. That’s why, it can be inferred that the 
hypermethylation of this CpG island is responsible for 
silencing of gene2 in normal cells and this gene may 
be activated through transformation dependent loss of 
DNA methylation in cancer cells.22–24
Repeated insertion appears to have played a major 
role during evolution of MAGE family. For instance, 
the long C-terminal domain of MAGE-D3 was most 
probably formed by serial duplications of decapeptide 
repeats. Also the N-terminal domains of MAGE-C1 
and MAGE-D1, are highly repetitive, must have under-
gone sequential duplication events.13,25 29 repeated 
short  peptides  containing  ∼12  amino  acids  were 
identified  in  gene2  protein  by  using  the  program 
RADAR26  (Table  3).  Although,  function  of  these 
repeats is unknown, it revealed that gene2 may be 
evolved from repeated insertion as found in MAGE 
family. To compare the repetitive pattern of gene2 with 
MAGE family protein, we have analyzed the repeats 
of MAGE-E1, MAGE-D1 and MAGE-D3 proteins 
(supplementary data). It was found that the repeats 
in  these  MAGE  family  members  are  not  identical 
and in some cases several variations in amino acids 
are found. The pattern of MAGE-D1 repeat is WQX-
PXX14 which is completely different from MAGE-D 
and MAGE-E1. However, these MAGE family mem-
bers are univocal in that sense that they all contain 
repeats (may be identical or different). On the other 
hand, our predicted gene2 contains TPG repeat which 
is found at several position of MAGE-E1.
The predicted secondary structure of gene2 showed 
more  extensive  β-strands  (∼44%)  and  coil  region 
(∼55%) distributed along the sequence (Fig. 4). From 
the secondary structure of entire MAGE-E1, it was 
found that N-terminal MHD2 domain contains exten-
sive coil and some β-stranded region but C-terminal 
MHD1 domain contains more a-helical regions along 
with some β-stranded regions. We have further ana-
lyzed the secondary structure pattern of repeats on 
MAGE-E1, MAGE-D1 and MAGE-D3 (supplemen-
tary data). Overall secondary structure pattern within 
the repeat region of these three family members was 
coil followed by β-strands but no a-helices which are 
very much likely to the secondary structure pattern of 
gene2 repeats although the amino acid composition 
of the repeats is slightly different.
To understand the functional association between 
gene2 and MAGE-E1, we have analyzed the protein 
function prediction result using two programs SVMProt 
and PFP. SVMProt results indicated that both gene2 
and MAGE-E1 belong to Zinc-binding protein family 
(Table 4). PFP result classified the function of pro-
tein according to the GO annotation categories. In the Amin et al
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Figure 4. secondary structure prediction of gene2 using hNN.
biological process categories, MAGE-E1 belongs to 
glia cell migration, nerve growth factor receptor sig-
naling pathway, neuronal migration, brain develop-
ment etc (Table 5) and gene2 belongs to neurogenesis 
whose specific outcome is the progression of nervous 
tissue  over  time,  from  its  formation  to  its  mature 
state  which  is  very  much  likely  to  MAGE-E1.  In 
the  molecular  function  categories,  gene2  matches 
with  MAGE-E1  in  exo-alpha-sialidase  activity 
and  inositol-polyphosphate  5-phosphatase  activity. 
Table 4. Comparative function prediction of MAGe-e1 and gene2 using sVMprot.
MAGe-e1 Gene2
Function p Value (%) Function p Value (%)
Zinc-binding 73.8 Zinc-binding 58.6
Nuclear receptors 65.4 Metal-binding 58.6
eC 3.4 hydrolases—Acting 
on peptide bonds 
(peptidases)
58.6
Calcium-binding 58.6
TC 1.B. 
Channels/pores—Beta-Barrel
porins 58.6Cancer-associated gene identification in silico
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Table 5. Comparative function prediction of MAGe-e1 and Gene2 using pFp.
MAGe-e1 Gene2
Biological process score Biological process score
Go.0008347 glia cell migration 2907203.66 Go.0009405 pathogenesis 760364.22
Go.0048011 nerve growth 
factor receptor
1164048.92 Go.0008380 RNA splicing 539421.38
signaling pathway
Go.0019233 perception 
of pain
961041.64 Go.0000398 nuclear mRNA 
splicing, via spliceosome
380866.18
Go.0001764 neuronal 
migration
868699.27 Go.0007520 myoblast 
fusion
365931.67
Go.0042060 wound healing 500313.41 Go.0007399 neurogenesis 222373.08
Go.0000074 regulation of cell 
cycle
473884.91 Go.0006512 ubiquitin cycle 205861.13
Go.0001558 regulation of cell 
growth
367704.56 Go.0016574 histone 
ubiquitination
205248.68
Go.0007585 respiratory 
gaseous exchange
316119.23 Go.0006816 calcium ion 
transport
187647.36
Go.0009062 fatty acid 
catabolism
263724.05 Go.0008104 protein 
localization
177700.20
Go.0007420 brain 
development
263045.24 Go.0042110 T-cell activation 171905.85
Molecular function score Molecular function score
Go.0043015 gamma-tubulin 
binding
550081.62 Go.0004308 
exo-alpha-sialidase activity
285616.06
Go.0016798 hydrolase activity, 
acting on glycosyl bonds
462333.96 Go.0046982 protein 
heterodimerization activity
258717.67
Go.0004308 
exo-alpha-sialidase activity
451789.12 Go.0008332 low voltage-
gated calcium channel 
activity
205987.38
Go.0004445 
inositol-polyphosphate 
5-phosphatase activity
222224.77 Go.0016874 ligase activity 190741.51
Go.0005515 protein binding 154771.23 Go.0030215 semaphorin 
receptor binding
161852.12
Go.0004674 protein serine/
threonine kinase activity
132065.84 Go.0008168 
methyltransferase activity
125300.40
Go.0003968 RNA-directed 
RNA polymerase activity
126483.06 Go.0004568 chitinase 
activity
112219.51
Go.0008289 lipid binding 119001.75 Go.0042809 vitamin D 
receptor binding
90949.14
Go.0017016 Ras interactor 
activity
106852.28 Go.0004842 ubiquitin-
protein ligase activity
87944.78
(Continued)Amin et al
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Table 5. (Continued)
MAGe-e1 Gene2
Go.0004806 triacylglycerol lipase activity 105189.12 Go.0004445 inositol-polyphosphate 
5-phosphatase activity
73545.05
cellular component score cellular component score
Go.0045211 postsynaptic membrane 1992254.90 Go.0030425 dendrite 561550.58
Go.0030425 dendrite 811128.08 Go.0009986 cell surface 229447.45
Go.0016010 dystrophin-associated 
glycoprotein complex
493386.26 Go.0005 891 voltage-gated calcium 
channel complex
220997.24
Go.0005813 centrosome 380800.79 Go.0005681 spliceosome complex 151073.10
Go.0048471 perinuclear region 276406.16 Go.0015629 actin cytoskeleton 125368.18
Go.0015629 actin cytoskeleton 178410.28 Go.0005737 cytoplasm 63162.21
Go.0046581 intercellular canaliculus 172680.03 Go.0016010 dystrophin-associated 
glycoprotein complex
58828.49
Go.0005634 nucleus 150265.62 Go.0005615 extracellular space 53737.16
Go.0005925 focal adhesion 136189.60 Go.0005643 nuclear pore 47225.56
In the cellular component categories, both gene2 and 
MAGE-E1 belong to dendrite, dystrophin-associated 
glycoprotein complex, actin cytoskeleton and nuclear 
region. Some differences in the prediction categories 
between gene2 and MAGE-E1 are observed. This may 
be due to the limited functional analysis on MAGE 
family protein and still now we don’t know enough 
about the expression and function of MAGE family 
proteins.14  From  these  analyses,  it  can  be  inferred 
that as a distant member, there are some functional 
alliance of gene2 with MAGE family protein.
However, low amino acid sequence homology was 
found for gene3 protein. But it showed high homology 
(99% identity) with some human ESTs (Supplementary 
data). For this reason, we are predicting that this gene 
is a novel one or it may have functions in regulation 
rather than coding.
conclusion
Even though these predicted genes should be further 
characterized  by  laboratory  means  before  their 
existence  can  be  conclusively  affirmed,  the  results 
presented in this study suggested and identified the 
location of a structurally similar gene of MAGE family 
on human chromosome 5. The findings can provide 
new insight in transcriptional activation of novel genes 
during malignant melanoma.
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